Longevity Biomarkers in Men vs Women: What Changes and Why
Longevity biomarkers shift differently by sex. See what the research shows about biological age, inflammation, and hormones, and what it means for men 30-55.
Do biological age markers actually look different for a 45-year-old man than for a 45-year-old woman, or is "biological age" just one universal number? The research says the pattern is more nuanced than a single clock ticking at different speeds. Sex shapes which biomarkers move first, how they should be read, and what a given lab value actually means for long-term health risk.
Table of contents
- What Counts as a Longevity Biomarker
- The Female Survival Paradox: Living Longer, Scoring Frailer
- Where Men's Biomarkers Diverge: Cardiometabolic and Hormonal Signals
- Epigenetic Clocks and DNA Methylation Age by Sex
- Muscle, Grip Strength, and VO2 Max: Functional Biomarkers Compared
- Inflammatory and Metabolic Markers: hs-CRP, HbA1c, and Lipids
- Why the Sex Longevity Gap Is Widening
- What This Means for a Man Tracking His Own Biomarkers
- FAQ
What Counts as a Longevity Biomarker
A biomarker of aging is a measurable trait, a blood marker, a physical performance test, or a DNA methylation pattern, that correlates with biological aging without perfectly predicting it. That definition comes from a 2023 review by Moqri and colleagues published in the aging biomarker literature (pmc.ncbi.nlm.nih.gov, 2023), and it matters because it sets expectations: no single number tells the whole story.
Common categories researchers track include:
- Epigenetic clocks, which estimate biological age from DNA methylation patterns
- Inflammatory markers, such as hs-CRP and IL-6
- Metabolic markers, including HbA1c and lipid panels
- Functional markers, such as grip strength and VO2 max
No single biomarker substitutes for biological age. Aging affects the cardiovascular, metabolic, immune, and musculoskeletal systems on different timelines, which is why researchers evaluate panels rather than one test result.
That panel-based approach is also why sex matters. A marker that reads as unremarkable for one sex can flag a meaningfully different trend for the other.
The Female Survival Paradox: Living Longer, Scoring Frailer
Here is where the "who ages faster" question gets genuinely interesting. A 2021 study by Hagg and colleagues in eLife found that women generally show lower biological age on molecular biomarkers than men of the same chronological age, a pattern consistent with women's longer average survival (elifesciences.org, 2021). At the same time, the same study found women report worse frailty and worse physical function scores late in life.
Men show close to the opposite pattern: biological age markers that often run higher, paired with better physical function test results. Researchers call this the sex-survival paradox, women live longer on average but report more disability along the way, while men show the reverse trade-off.
The practical takeaway is not that one sex "ages better." It's that biomarker interpretation cannot be sex-neutral.
| Pattern | Women | Men |
|---|---|---|
| Molecular biological age (Hagg et al., 2021) | Tends to run lower | Tends to run higher |
| Physical function / frailty | Reports worse late-life frailty | Reports better function scores |
| Average survival | Longer | Shorter |
A marker that would concern a clinician in a man's chart may read differently against female reference ranges, and the reverse is also true.
Where Men's Biomarkers Diverge: Cardiometabolic and Hormonal Signals
Between ages 30 and 55, men tend to show earlier and steeper increases in visceral fat, fasting glucose, and blood pressure, all markers tracked in most standard longevity panels. These shifts don't happen on a fixed schedule, but the direction is consistent enough that clinicians watch this cluster closely in midlife men.
Total and free testosterone also decline gradually with age in men. That decline is worth naming precisely: it is a hormonal shift that intersects with metabolic and body-composition biomarkers, not a standalone aging clock on its own. A falling testosterone value doesn't, by itself, explain a rising HbA1c or an expanding waistline, and it shouldn't be read as if it does.
If hormonal changes seem to be tracking alongside metabolic or body-composition shifts, the reasonable next step is an evaluation, not self-diagnosis from a single number.
A single low testosterone reading is a data point, not a verdict. Levels fluctuate with time of day, sleep, illness, and lab method, which is why a licensed clinician typically confirms low levels with repeat testing before drawing conclusions.
For men weighing whether hormone therapy is relevant to their own biomarker trends, TRT and Body Composition: What Changes Clinicians Typically Expect walks through what change over time realistically looks like.
Epigenetic Clocks and DNA Methylation Age by Sex
Epigenetic clocks estimate biological age from patterns of DNA methylation, chemical marks on DNA that shift in predictable ways as cells age. They are among the most studied biomarkers of aging in the current literature, according to the Moqri et al. 2023 review (pmc.ncbi.nlm.nih.gov, 2023).
Sex differences in methylation-based age estimates show up consistently across studies. The Hagg et al. 2021 eLife paper notes, though, that the underlying mechanisms behind these differences remain only partly understood (elifesciences.org, 2021). Researchers can observe the pattern more confidently than they can fully explain it.
That gap between observation and mechanism matters for how these tests should be used. Epigenetic age testing is a research and consumer-wellness tool, not a diagnostic test. A result should prompt a conversation with a clinician, not an independent decision about treatment or lifestyle overhaul.
Muscle, Grip Strength, and VO2 Max: Functional Biomarkers Compared
Cardiorespiratory fitness, measured as VO2 max, and grip strength are two of the most widely cited functional longevity biomarkers, because both correlate with all-cause mortality risk across large population studies referenced in the Moqri et al. 2023 review (pmc.ncbi.nlm.nih.gov, 2023).
Men typically post higher absolute grip strength and VO2 max values than women at every adult age. That's a physiological baseline difference, not a health verdict, which is why researchers use sex-specific reference ranges rather than one universal cutoff.
| Marker | Typical pattern | Why it's tracked |
|---|---|---|
| Grip strength | Higher absolute values in men at every age | Correlates with all-cause mortality risk |
| VO2 max | Higher absolute values in men at every age | Correlates with cardiovascular and all-cause mortality risk |
| Trend over years | Declines with age regardless of sex | More informative than a single reading |
The single most useful habit here isn't comparing your number to a population chart. It's tracking your own trend over repeated tests, since both markers decline with age regardless of sex, and the slope of that decline is more informative than any one data point. For a deeper look at how these functional markers fit alongside lab work, see Longevity Biomarkers Beyond Bloodwork: HRV, VO2 Max, and Grip Strength Explained.
Inflammatory and Metabolic Markers: hs-CRP, HbA1c, and Lipids
Chronic low-grade inflammation, often measured with hs-CRP, is one of the recognized hallmarks of aging discussed in the longevity biomarker literature (pmc.ncbi.nlm.nih.gov, 2023). It's a marker clinicians watch not because a single elevated result is alarming on its own, but because it flags a process worth monitoring.
Men and women show different baseline patterns for lipid markers across midlife. That's the reason bloodwork panels are interpreted against sex-specific and age-specific reference ranges, rather than compared to one fixed universal target.
A few practical points worth holding onto:
- A single elevated hs-CRP or HbA1c result can reflect a temporary illness, poor sleep, or recent exertion, not necessarily a chronic trend.
- A rising trend across repeated tests is more clinically meaningful than any one reading.
- These markers are most useful when reviewed alongside body composition and activity history, not in isolation.
Why the Sex Longevity Gap Is Widening
The life expectancy gap between men and women in the United States has been widening, according to a 2024 report from the Harvard T.H. Chan School of Public Health, driven in part by preventable causes of death concentrated among men (hsph.harvard.edu, 2024). That's a population trend, not a life sentence for any individual man, but it's worth sitting with.
The Max Planck Institute for Biology of Ageing attributes part of women's longer average lifespan to a mix of behavior and biology: women tend to visit doctors earlier and more often, smoke and drink less on average, and engage more consistently with preventive care, alongside biological factors tied to sex hormones (age.mpg.de). No single cause explains the whole gap.
The line worth remembering: these are population-level, behavioral, and genetic explanations, not individual predictions. An individual man's biomarker trajectory depends on his own labs, fitness, and family history, not on a national average.
What This Means for a Man Tracking His Own Biomarkers
Because male and female biomarker patterns diverge in documented ways, a longevity panel is most useful when it's interpreted against sex-specific reference ranges and repeated over time, rather than read as a single snapshot compared to a generic chart.
A reasonable baseline panel commonly includes:
- Hormone levels (including testosterone, when clinically relevant)
- Metabolic markers (fasting glucose, HbA1c)
- A lipid panel
- Inflammatory markers (hs-CRP)
- A functional fitness measure, such as grip strength or VO2 max
If hormone therapy becomes part of that conversation, it's worth naming the pathway plainly: any testosterone therapy is prescribed by a licensed clinician and compounded and dispensed by a 503A partner pharmacy, not manufactured or sold as a standalone product. It is not positioned as identical to, or a substitute for, any FDA-approved brand-name hormone product, and no specific outcome, weight change, testosterone level, or energy improvement, can be guaranteed for an individual.
LodeRx patients can review a longevity-focused bloodwork panel with a state-licensed EliteCare clinician, available in all 50 states, to put individual results in context rather than measuring them against generic population averages.
FAQ
Do men and women age at different biological rates?
Research suggests the pattern is more nuanced than a simple rate difference. A 2021 eLife study by Hagg and colleagues found women generally show lower biological age on molecular biomarkers, consistent with longer survival, but also report worse frailty and physical function late in life. Men show the opposite pattern: higher biological age markers but better physical function scores.
Why do women typically live longer than men?
The Max Planck Institute for Biology of Ageing points to a mix of genetics and behavior: women tend to visit doctors earlier and more often, smoke and drink less on average, and pay more attention to preventive health, alongside biological factors tied to sex hormones. No single cause fully explains the gap.
What is the strongest predictor of longevity?
No single biomarker reliably predicts longevity on its own. A 2023 review by Moqri and colleagues found the field favors composite panels combining functional markers like grip strength and VO2 max with molecular markers like epigenetic clocks and inflammatory markers, since aging affects multiple systems at different rates.
Should men track the same longevity biomarkers as women?
The core categories overlap, inflammatory, metabolic, hormonal, and functional markers, but interpretation differs. Sex-specific reference ranges matter because men and women show different baseline patterns for markers like grip strength, VO2 max, and lipids, as documented in the Hagg et al. 2021 research on sex differences in biological aging.
Can hormone therapy change a man's longevity biomarkers?
Addressing a clinically low testosterone level, when prescribed by a licensed clinician, may influence related metabolic and body-composition markers over time, but it does not reverse biological age or guarantee a specific outcome. Any hormone therapy should follow an individualized evaluation, including bloodwork, with a licensed clinician rather than self-directed use.
If your own labs, or a recent grip-strength or VO2 max test, have you wondering what the numbers actually mean for you, the next reasonable step is to review a longevity-focused bloodwork panel with a state-licensed EliteCare clinician rather than benchmarking a single result against a population chart.